RCM’s Institutional Equities division specializes in equity research, sales and execution in emerging market equities. Combining a thorough understanding of emerging economies with global expertise and international best practices, our sales team works closely with the equity research team to deliver unencumbered, conviction-based reports. Benefiting from the global interchange of the sales team’s ideas and coverage across multiple time-zones and markets, we pride ourselves in the speed-to-market and agility of our analysis, which contains functional interpretation and customized solutions.  This equity research is complemented by macro, country and thematic economic analysis, produced by in-house specialists across time zones.

We have licensed offices in the UK, India, Hong Kong, Singapore, Sri Lanka and Dubai, with some 450 empaneled institutional clients and more than 170 employees.

*The services described on this Web site may not be available in all jurisdictions or to all persons. For further detail, please see our Disclaimer.












Religare Capital Markets Limited, India: Member: NSE: SEBI Registration No. INB231302630, INF231302630, TM Code: 13026  BSE: SEBI Registration No. INB011302636, INF011302636. TM Code: 3240 I SEBI Merchant Banking Registration No.: INM000011062

Attention Investors
"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"